In a Sept. 9 letter to faculty and staff, OSU President Kristina Johnson, PhD, wrote that CFO Mark Larmore and Andrew Thomas, MD, chief clinical officer and senior associate vice president of health sciences, have been named interim replacements, effective immediately.
“Mr. Larmore will focus on operations and finance while Dr. Thomas will take the lead on clinical affairs and external relations,” Dr. Johnson wrote. “Each will report directly to me and serve on my President’s Cabinet.”
Mr. Larmore has served as the medical center’s CFO since 2015, while Dr. Thomas has served in a variety of leadership roles throughout his tenure, according to the announcement.
Dr. Paz’s resignation will become effective Oct. 3. He will start a new role as executive vice president at Stony Brook (N.Y.) University.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
